How is Artificial Intelligence for Drug Discovery Bringing Revolution?

Quick Summary

Table of Contents

Introductio

Every sector needs reformation and technological adaptation, especially healthcare and drug discovery if it needs to be precise. COVID-19 has changed the times and surged the demand for rapid treatment and vaccine development.

According to the National Library of Medicine, artificial intelligence (AI) has been heavily bolstered in drug and vaccine research to fight COVID-19. AI tools and computational approaches have facilitated the rapid identification of existing drugs with the potential to inhibit the SARS-CoV-2 virus by analyzing diverse datasets.

The effectiveness and promptness show how AI could speed up drug discovery and nullify diseases’ adverse or lethal effects. Therefore, not prioritizing investment in AI or not giving enough attention could only allow other entrepreneurs to thrive and succeed. Artificial Intelligence for drug discovery is a sure-shot investment opportunity that shouldn’t be missed now.

Role of Artificial Intelligence in Drug Discovery

Drug discovery is a phase-based process, and traditionally, every phase faces many challenges. However, AI for drug discovery has overcome almost all the challenges. Besides, you must understand how different cutting-edge technologies are used in each drug-discovery phase. Let’s understand the role of AI in drug discovery and how cutting-edge technologies benefit it.

Target Identification & Validation

Challenges:
Building a drug requires identifying the suitable molecules involved in the diseases, which consumes resources using traditional methods.

AI Solutions:
On the other hand, the role of AI in drug discovery ensures the evaluate a large dataset, patient health records, and protein structures to provide drug molecules. Not only does AI suggest new drug formation, but it also evaluates if the existing drug requires minor molecular change and is effective in curing diseases.

Machine Learning:
Machine learning initiates new drug discovery targets. Here, supervised learning algorithms are trained on massive datasets encompassing existing drugs, their known targets, and disease-related information. The AI models for drug discovery analyze genetic and protein data to identify potential new targets associated with a specific disease.

Lead Discovery & Optimization

Challenges:
Another major challenge in drug discovery is finding the right initiation point (lead molecules), which takes time and requires a hefty capital investment.

AI Solutions:
AI’s capability of evaluating libraries of chemical compounds plays a crucial role in lead discovery since the suitable chemical compound is essential to combating disease. Beyond lead identification, AI suggests altering existing drugs to increase their potency against diseases.

Deep Learning:
Deep learning takes the lead in drug discovery and optimization. Convolutional neural networks (CNNs), a type of deep learning model, excel at analyzing the intricate structures of molecules. These powerful models can virtually screen vast libraries of compounds, predicting how they might interact with the identified target protein. This allows researchers to prioritize promising leads with a strong affinity for the target, significantly accelerating the process.

Virtual Screening & Design

Challenges:
Drug testing is another time-consuming factor for drug testers. With physical synthesizing, drug testing demands more workforce and capital.

AI Solutions:
AI for drug discovery ensures virtual screening to replicate molecules to target disease proteins at an atomic level to analyze their potency. As a result, researchers could identify capable molecules and sort them out for further exploration without physical synthesis.

Generative Adversarial Networks:
Virtual screening and design leap forward with Generative Adversarial Networks (GANs). This cutting-edge deep learning technique pits two neural networks against each other. One network, acting as a creator, generates new candidate drug molecules. The other, the critic, tries to distinguish these new molecules from known drugs. This competitive process fosters innovation, leading to the generation of increasingly sophisticated and drug-like candidate molecules.

Clinical Trial Design & Optimization

Challenges:
Drug clinical trials require volunteer patients and heavy spending. Moreover, drug discoverers still face the challenge of designing a single and efficient dose.

AI Solutions:
AI for drug discovery, especially in clinical trial design and optimization. AI evaluates patient data and disease profiles to match precisely related patient populations for clinical trials. Moreover, clinical trials can be optimized to foresee trial results and adverse effects.

Natural Language Processing:
Natural Language Processing (NLP) empowers AI to analyze vast medical literature, clinical trial data, and patient records. By identifying patterns and trends within this data, NLP can predict potential patient responses to a drug. This allows for optimized clinical trial design by selecting the most suitable patient populations and tailoring dosage strategies, leading to more efficient and informative trials.

AI in Drug Discovery: Impact on Healthcare

Artificial Intelligence for drug discovery has shown notable results, out of which we have listed a few of them below:

COVID-19 Research

COVID is accountable for a significant shift in attention towards the healthcare sector. Not only does the industry attract heavy investment, but it also wholeheartedly welcomes cutting-edge technologies. Artificial Intelligence for drug discovery, especially for COVID-19, has contributed significantly to drug developers by offering specific compounds to treat the virus.

Alzheimer’s Therapeutic Research

Alzheimer’s has a protein called beta-secretase that progresses the disease. Still, with the help of Machine Learning algorithms, drug discoverers can target complicated neurodegenerative disorders and offer effective therapeutic solutions for the said disease.

Cancer Treatment Research

Artificial intelligence for drug discovery has significantly contributed to identifying cancer treatment compounds. Using deep learning algorithms, cancer-related compounds were scrutinized to derive promising results.

How Have Existing Drug Discovery Businesses Benefited From Artificial Intelligence?

Benevolent AI is one of the leading AI-driven companies that use AI for drug discovery and has achieved tremendous results. The company handled Amyotrophic Lateral Sclerosis, a neurodegenerative disease for which several solutions were provided using Artificial Intelligence.

Below are the detailed challenges, AI-driven solutions, and outcomes of the solutions. Let’s understand what impact Artificial Intelligence has on drug discovery.

Challenge:
It was difficult to trace the complicated cellular process and find an effective treatment for neurodegenerative diseases.

Solution:
Using Artificial Intelligence, Benevolent evaluated scientific literature, patient data, and the disease’s protein structure. As a result, they were able to figure out an unknown cellular pathway that gives ALS a tough fight.

Outcome:
Benevolent succeeded by identifying existing drugs to intercept the protein structure and treat ALS. As a result, the company could save time and resources, which was a significant challenge in traditional drug discovery methods.

The Evolving Landscape of Artificial Intelligence for Drug Discovery: Insights from a Scientist in the Field

Here’s a glimpse into what the future may have in store;

1. Improved Target Identification and Discovery of Potential Hits:

Historically, pinpointing drug targets has been a time-consuming endeavor. In contrast, AI can sift through datasets containing information, protein structures, and disease models to swiftly identify potential targets. This accelerated process enables researchers to concentrate on avenues that show promise for drug development.

Fact Check: A study published in Nature Biotechnology in 2020 illustrated that AI models exhibited accuracy in identifying drug targets for Alzheimer’s disease compared to conventional approaches.

2. Drug Design and Generation of Lead Compounds:

Through AI algorithms, it is possible to analyze the structure and attributes of existing drugs to forecast their interactions with targets. This capability facilitates the creation of repositories harboring drug candidates, thereby significantly cutting down on both time and expenses associated with traditional drug design.

This new method paves the way for more cost-effective development of novel treatments.

Insight from the Industry: As per a study conducted by McKinsey & Company, utilizing AI in drug discovery has the potential to cut development timelines in half and reduce costs by up to 30%.

3. Utilizing Existing Medications and Minimizing Drug Failures:

AI can sift through volumes of data from trials to pinpoint existing medications that could be beneficial for new therapeutic purposes. This “repurposing drugs” strategy offers a more economical route to introducing treatments to the market. Researchers could shorten development timelines and lower costs by using existing medications.

A Practical Example: In 2018, scientists employed AI technology to determine that a medication initially created for rheumatoid arthritis could also effectively treat ALS (sclerosis). This finding demonstrates how AI can uncover applications for existing drugs.

4. Tailored Medicine and Customized Treatments:

AI can assess an individual’s composition and medical background to predict how they respond to different drugs. In a study published in Nature Response on various medications, This personalized approach in medicine could result in treatments with fewer side effects. AI is poised to enhance outcomes and develop successful therapies by customizing treatment plans based on each patient’s needs.

5. Advancement in Science:

In 2021, a study published in Nature Genetics revealed that AI can accurately predict how a patient will respond to cancer immunotherapy. This development sets the stage for creating treatment plans for cancer that are both effective and have minimal side effects.

While AI’s potential is vast, some challenges must be addressed. These include ensuring that AI models are accurate and easy to interpret, handling the data needed for training, and dealing with issues in drug development. It is crucial to tackle these challenges by using AI responsibly and effectively to discover drugs.

Conclusion